Undas et al. suggested that simvastatin depresses blood clotting by inhibiting the activation of prothrombin, factor V and factor XIII and presents antithrombotic and anti-inflammatory effects in patients with hypercholesterolemia [120]. This evidence concerns the gene F2 and familial hypercholesterolemia.